Pendergist v. Pendergrass

961 S.W.2d 919, 1998 Mo. App. LEXIS 210, 1998 WL 49138
CourtMissouri Court of Appeals
DecidedFebruary 10, 1998
DocketWD 54315
StatusPublished
Cited by20 cases

This text of 961 S.W.2d 919 (Pendergist v. Pendergrass) is published on Counsel Stack Legal Research, covering Missouri Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pendergist v. Pendergrass, 961 S.W.2d 919, 1998 Mo. App. LEXIS 210, 1998 WL 49138 (Mo. Ct. App. 1998).

Opinion

ULRICH, Chief Judge, Presiding Judge.

Patrick Pendergist appeals the trial court’s order granting the motions for summary judgment filed by the defendants, Kelly B. Pendergrass, M.D., Prime Health, Kansas City, Inc., Health Midwest, Inc. d/b/a Research Medical Center, Humana, Inc. d/b/a Humana Health Care Plans, and Soloman Lewitton, M.D. (collectively “Defendants”). Despite having tested negative for the Human Immunodeficiency Virus (HIV) four times in four years, Mr. Pendergist sued Defendants for negligent infliction of emotional distress and fraudulent misrepresentation premised upon his fear of contracting Acquired Immunodeficiency Syndrome (AIDS) or hepatitis B, another communicable blood disease, as a result of receiving human whole blood Factor VIII rather than Recombinant Factor VIII, which he claimed to have requested, dining his hernia surgery in 1993. The question presented is whether a plaintiff may recover damages for emotional distress based on a fear of contracting AIDS or hepatitis B absent proof of actual exposure to HIV. The judgment of the trial court is affirmed.

FACTS

Patrick Pendergist is 48 years old. At the age of seven, he was diagnosed with hemophilia, a condition of the circulatory system characterized by delayed clotting of the blood and difficulty in controlling hemorrhage. Mr. Pendergist saw his physician on June 9, 1993, and complained of a lump in the right groin region. Mr. Pendergist’s physician diagnosed the injury, the apparent result of an automobile accident, as a hernia, and Mr. Pendergist elected to have the hernia surgically repaired.

Mr. Pendergist had previously undergone bone spur and ganglion surgery. On both occasions, he received human whole blood Factor VIII. Factor VIII is a clotting agent that prevents excessive bleeding. Despite having received human whole blood Factor VIII during two prior surgeries, Mr. Pendergist claimed that before his hernia surgery in 1993, he specifically told all of the treating medical professionals that he wanted “synthetic” Factor VIII, i.e., Recombinant Factor VIII, rather than human whole blood Factor VIII. He requested Recombinant Factor VIII because he believed that it was (1) safer than human whole blood Factor VIII and (2) incapable of transmitting life-threatening diseases. Mr. Pendergist conceded, however, that none of the health care providers told him he would receive Recombinant Factor VHI.

Human whole blood Factor VIII is generally prepared from large plasma pools obtained from thousands of donors, and without adequate inactivation of viruses, it can transmit HIV and hepatitis B. Consequently, human whole blood Factor VIII is treated with a solvent and a detergent to eliminate the HIV and hepatitis B viruses. Since the virus-sterilization process was introduced in 1985, many thousands of patients have received more than seven million doses of blood products, including human whole blood Factor VIII, without transmission of HIV or hepatitis B infections. Recombinant Factor VIII, however, is derived from introduction of Factor VIII genes into Chinese hamster cells. Because human albumin, a protein, is added as a stabilizer, a purification process utilizing affinity and ion exchange chromatography is necessary.

Mr. Pendergist experienced successful hernia surgery at Research Medical Center in Kansas City on July 2, 1993. Human whole blood Factor VIII was administered to Mr. Pendergist during the surgery. Upon learning after the surgery that he received human whole blood Factor VIII, Mr. Pendergist claims that he began to feel angry, frustrated, and helpless. He claims that he became distrustful and paranoid, experienced bizarre *922 dreams, and grew concerned about contracting AIDS or hepatitis B.

AIDS is the most severe manifestation of infection with Human Immunodeficiency Virus (HIV). Centers for Disease Control and Prevention (CDC) National AIDS Clearinghouse: Information on HIV/AIDS (last modified March 1997) <http:// www.cdcnac.org>. The CDC lists numerous opportunistic infections and cancers that, in the presence of HIV infection, constitute AIDS diagnosis. Id. Persons infected with “full-blown AIDS” frequently suffer from infections of the lungs, brain, eyes, and other organs and from debilitating weight loss, diarrhea, and a type of cancer called Kaposi’s Sarcoma. Id.

HIV is a retrovirus that attacks the human immune system. Faya v. Almaraz, 329 Md. 435, 620 A.2d 327, 329 (Md.1993). The virus invades host cells, notably certain lymphocytes, replicates itself, weakens the immune system, and ultimately destroys the body’s capacity to ward off disease. Id. The HIV virus is not spread casually. The fluids that can transmit the virus are blood, semen, vaginal fluids, and breast milk, and the virus is only transmitted if fluid from the carrier is introduced into the bloodstream of another individual. Id. (citing U.S. Dept. of Health and Human Servs., Surgeon General’s Report on Acquired Immune Deficiency Syndrome 16 (1987)). Thus, the typical modes of transmission of HIV include sexual contact, exposure to infected blood or blood components, and perinatally from mother to infant. DeMilio v. Schrager, 285 N.J.Super. 183, 666 A.2d 627, 630 n. 2 (N.J.Super.Ct. Law Div. 1995). The presence of HIV is detected by a laboratory blood test for antibodies to the virus. Although there is often a long latency period between infection with HIV and the onset of AIDS, enzyme immunoassay tests are considered to be 99% accurate three months after exposure. Brown v. New York City Health and Hosp. Corp., 225 A.D.2d 36, 648 N.Y.S.2d 880, 885 (N.Y.App.Div.1996). Ninety-five percent of HIV-infected individuals test positive for the virus within six months of exposure. Id. An individual who tests negative for HIV antibodies more than six months after a potential exposure is, therefore, unlikely to become infected with the virus as a result of that exposure. Id.

In November 1993, Mr. Pendergist underwent an enzyme immunoassay test to determine whether he had been exposed to the HIV virus, and the test was negative. He was tested again for HIV and hepatitis in the summers of 1994, 1995, and 1996 with negative results.

Mr. Pendergist filed his petition for damages against Defendants on June 27, 1995. He sought over $5.2 million in damages for his claimed emotional injuries under two theories: negligent infliction of emotional distress and fraudulent misrepresentation. Defendants filed separate motions for summary judgment arguing that without evidence of actual exposure to the HIV or hepatitis virus as a result of his having received human whole blood Factor VIII during hernia surgery in 1993, Mr. Pendergist’s claim for emotional distress damages based on a fear of contracting AIDS failed as a matter of law. The trial court found that absent actual exposure to the HIV or hepatitis virus, Mr. Pen-dergist’s claimed emotional distress based on the fear of contracting AIDS or hepatitis was unreasonable and granted Defendant’s motions. This appeal followed.

RECOVERY FOR EMOTIONAL DISTRESS FOR FEAR OF CONTRACTING AIDS

In his sole point on appeal, Mr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

M.N. v. MultiCare Health Sys., Inc.
Washington Supreme Court, 2024
Sledge v. United States Bureau of Prisons
883 F. Supp. 2d 71 (District of Columbia, 2012)
Corrington v. United States
767 F. Supp. 2d 956 (S.D. Illinois, 2011)
Jarrett v. Jones
258 S.W.3d 442 (Supreme Court of Missouri, 2008)
Space Planners Architects, Inc. v. Frontier Town-Missouri, Inc.
107 S.W.3d 398 (Missouri Court of Appeals, 2003)
Williams v. Finance Plaza, Inc.
78 S.W.3d 175 (Missouri Court of Appeals, 2002)
Coca-Cola Bottling Co. v. Hagan
813 So. 2d 167 (District Court of Appeal of Florida, 2002)
Shumosky v. Lutheran Welfare Services of Northeastern PA, Inc.
784 A.2d 196 (Superior Court of Pennsylvania, 2001)
Thornburg v. Federal Express Corp.
62 S.W.3d 421 (Missouri Court of Appeals, 2001)
M.C. v. Yeargin
11 S.W.3d 604 (Missouri Court of Appeals, 2000)
SOUTH CENT. REG. MEDICAL CTR. v. Pickering
749 So. 2d 95 (Mississippi Supreme Court, 1999)
John & Jane Roes, 1-100 v. FHP, Inc.
985 P.2d 661 (Hawaii Supreme Court, 1999)
Soper v. Bopp
990 S.W.2d 147 (Missouri Court of Appeals, 1999)
Majca v. Beekil
701 N.E.2d 1084 (Illinois Supreme Court, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
961 S.W.2d 919, 1998 Mo. App. LEXIS 210, 1998 WL 49138, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pendergist-v-pendergrass-moctapp-1998.